Search - tctmd.com

Displaying 1 - 20 of 40

Sort: Relevancy | Date

News Conference News AHA 2016

商业健康保险的年轻患者的压力测试可能会增加

L.A. McKeown

November 23, 2016

News Conference News AHA 2016

Stress Testing May Be Increasing Among Younger Patients With Commercial Health Insurance

L.A. McKeown

November 23, 2016

News Conference News AHA 2016

La Pruebas de Esfuerzo podrían estar Aumentando en Pacientes Más Jóvenes con Seguro Médico Comercial

L.A. McKeown

November 23, 2016

News Conference News AHA 2016

类药物相关的肌肉疼痛？GAUSS-3 分析称可能基因决定的

Michael O'Riordan

November 22, 2016

News Conference News AHA 2016

¿Dolor Muscular Secundario a las Estatinas? Según el Análisis GAUSS-3 Podría ser Genético

Michael O'Riordan

November 22, 2016

News Conference News AHA 2016

Statin-Associated Muscle Pain? It May Be Your Genes, Says GAUSS-3 Analysis

Michael O'Riordan

November 22, 2016

News Conference News AHA 2016

Chest Pain Clinic Reduces Emergency Department and Hospital ‘Frequent Fliers’

Michael O'Riordan

November 21, 2016

News Conference News AHA 2016

Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women

L.A. McKeown

November 17, 2016

News Conference News AHA 2016

全国数据认为 PCI 在没有外科手术后备支援的中心“可能实施”

Yael L. Maxwell

November 16, 2016

News Conference News AHA 2016

Según Datos a Nivel Nacional, las PCI realizadas en Centros Sin Soporte Quirúrgico ‘Probablemente No Tengan Problemas’

Yael L. Maxwell

November 16, 2016

News Conference News AHA 2016

PCI at Centers Without Surgical Backup ‘Probably OK,’ Nationwide Data Suggests

Yael L. Maxwell

November 16, 2016

Presentation AHA 2016

Arterial Revascularization Trial (ART)

Presenter: David P. Taggart

November 15, 2016

AEGIS-I Trial: The Safety and Tolerability of CSL112

Presentation AHA 2016

The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I)

Presenter: Michael Gibson

November 15, 2016

Presentation AHA 2016

FUnctional Testing Underlying REvascularization: The FUTURE trial

Presenter: Gilles Rioufol

November 15, 2016

News Conference News AHA 2016

Incomplete Revascularization Linked With Increased MACE in Subsequent Noncardiac Surgery

Michael O'Riordan

November 15, 2016

News Conference News AHA 2016

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Michael O'Riordan

November 14, 2016

News Conference News AHA 2016

Rivaroxaban-Based Double or Triple Therapy Cuts Bleeding in Patients With A-fib Undergoing PCI: PIONEER AF-PCI

Todd Neale

November 14, 2016

News Conference News AHA 2016

Secondhand Smoke Exposure Associated With Increased Risk of Coronary Atherosclerosis

Michael O'Riordan

November 13, 2016

News Conference News AHA 2015

Varenicline Helps ACS Patients Quit Smoking, But Effect Wanes

Todd Neale

November 12, 2015

News Conference News AHA 2015

Reversal Agents Safely Stop Effects of Novel Oral Anticoagulants

Yael L. Maxwell

November 10, 2015

Advertisement

商业健康保险的年轻患者的压力测试可能会增加

Stress Testing May Be Increasing Among Younger Patients With Commercial Health Insurance

La Pruebas de Esfuerzo podrían estar Aumentando en Pacientes Más Jóvenes con Seguro Médico Comercial

类药物相关的肌肉疼痛？GAUSS-3 分析称可能基因决定的

¿Dolor Muscular Secundario a las Estatinas? Según el Análisis GAUSS-3 Podría ser Genético

Statin-Associated Muscle Pain? It May Be Your Genes, Says GAUSS-3 Analysis

Chest Pain Clinic Reduces Emergency Department and Hospital ‘Frequent Fliers’

Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women

全国数据认为 PCI 在没有外科手术后备支援的中心“可能实施”

Según Datos a Nivel Nacional, las PCI realizadas en Centros Sin Soporte Quirúrgico ‘Probablemente No Tengan Problemas’

PCI at Centers Without Surgical Backup ‘Probably OK,’ Nationwide Data Suggests

Arterial Revascularization Trial (ART)

The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I)

FUnctional Testing Underlying REvascularization: The FUTURE trial

Incomplete Revascularization Linked With Increased MACE in Subsequent Noncardiac Surgery

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Rivaroxaban-Based Double or Triple Therapy Cuts Bleeding in Patients With A-fib Undergoing PCI: PIONEER AF-PCI

Secondhand Smoke Exposure Associated With Increased Risk of Coronary Atherosclerosis

Varenicline Helps ACS Patients Quit Smoking, But Effect Wanes

Reversal Agents Safely Stop Effects of Novel Oral Anticoagulants

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content